AN2 Therapeutics
ANTX
ANTX
36 hedge funds and large institutions have $8.78M invested in AN2 Therapeutics in 2025 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
-1
Holders Change %
-2.7%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
9
Reduced
5
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
BCM
BML Capital Management
Zionsville,
Indiana
|
-$7.82M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.36M |
| 3 |
AC
Aldebaran Capital
Carmel,
Indiana
|
-$553K |
| 4 |
Two Sigma Advisers
New York
|
-$186K |
| 5 |
Two Sigma Investments
New York
|
-$112K |
